The administration of Pep3 demonstrated no obvious effects on the body weight of the ESCC mice (Fig. 7B), while it could significantly prolong the survival of the mice (P = 0.036) (Fig. 7C). Here, VPS18 is linked to esophageal squamous cell carcinoma.